title: Tuberculous orchiepididymitis during 1978-2003 period: review of 34 cases and role of 16S rRNA amplification.
abstract: Genitourinary tuberculosis was diagnosed in 543 patients in Spanish hospital from 1978 through 2003. Of the 371 male 34 (9.2%) had orchiepididymitis. Mean age was 52.7 years and the presenting symptom was scrotal swelling and/or pain. Over 50% of cases involved the right ovotestis. Associated renal tuberculosis and active disease in extraurological organs presented in 64% and 19.2% of cases, respectively. Diagnosis was established by culture of Mycobacterium tuberculosis recovery from urine and/or purulent scrotal exudate. Genomic amplification techniques aided the diagnosis in 8 patients. Treatment was rifampin, isoniazide, and pyrazinamide or ethambutol. Eight patients required combined medical and surgical treatment.
authors.affiliation: Hospital Virgen de la Salud, Toledo, Spain. naggoga@yahoo.es
authors.forename: Ignacio
authors.initials: I
authors.lastname: Gómez García
authors.forename: Enrique
authors.initials: E
authors.lastname: Gómez Mampaso
authors.forename: Javier
authors.initials: J
authors.lastname: Burgos Revilla
authors.forename: Marta Romero
authors.initials: MR
authors.lastname: Molina
authors.forename: Antonio
authors.initials: A
authors.lastname: Sampietro Crespo
authors.forename: Luis Alvarez
authors.initials: LA
authors.lastname: Buitrago
authors.forename: Antonio
authors.initials: A
authors.lastname: Gómez Rodríguez
authors.forename: Fernando
authors.initials: F
authors.lastname: Baquero
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000995:Antitubercular Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D015897:Comorbidity; D004823:Epididymitis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology / Q000601:surgery; D004977:Ethambutol / Q000627:therapeutic use; D005122:Exudates and Transudates / Q000382:microbiology; D015658:HIV Infections / Q000453:epidemiology; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000145:classification / Q000235:genetics / Q000302:isolation & purification*; D009920:Orchitis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology / Q000601:surgery; D011472:Prostatitis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D011718:Pyrazinamide / Q000627:therapeutic use; D012336:RNA, Ribosomal, 16S / Q000235:genetics*; D012189:Retrospective Studies; D021521:Ribotyping; D012293:Rifampin / Q000627:therapeutic use; D012611:Scrotum / Q000382:microbiology; D013030:Spain / Q000453:epidemiology; D014389:Tuberculosis, Male Genital / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology / Q000601:surgery; D014398:Tuberculosis, Renal / Q000453:epidemiology; D014556:Urine / Q000382:microbiology
chemical_list: D000995:Antitubercular Agents; D012336:RNA, Ribosomal, 16S; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin